Paper Title
DRUG-DRUG INTERACTIONS WITH DAPAGLIFLOZIN: A REVIEW
Article Identifiers
Registration ID: IJNRD_226711
Published ID: IJNRD2408223
: Click Here to Get
About Hard Copy and Transparent Peer Review Report
Authors
Keywords
Diabetes mellitus, Glycemic control, Sodium-glucose cotransporter-2 (SGLT2) Inhibitors, Type 2 diabetes mellitus, Dapagliflozin, polypharmacy, Drug-drug interactions, Optimising therapy
Abstract
Diabetes mellitus presents a significant global health issue, necessitating innovative strategies to enhance patient outcomes. Effective glycemic control is crucial for mitigating the risk of complications such as diabetic nephropathy and cardiovascular disease. Traditional oral antidiabetic agents often fall short in long-term glycemic management, underscoring the need for advanced treatments. Sodium-glucose cotransporter-2 (SGLT2) inhibitors offer a novel approach for managing type 2 diabetes mellitus. These agents have demonstrated efficacy in reducing glycated hemoglobin without inducing hypoglycemia, either as monotherapy or in combination with various other glucose-lowering agents. They also provide additional benefits, such as promoting weight loss and lowering arterial blood pressure. Dapagliflozin, a highly potent, reversible, and selective SGLT2 inhibitor, has emerged as a cornerstone in the management of type 2 diabetes mellitus. It represents an attractive therapeutic option for patients whose blood glucose levels are inadequately controlled by metformin and/or other oral antidiabetic drugs (OADs), offering a complementary insulin-independent mechanism of action. Dapagliflozin lowers blood glucose by promoting glycosuria and provides cardiovascular and renal benefits, leading to its widespread use. However, given the polypharmacy typical in diabetic patients, understanding the drug-drug interactions (DDIs) of dapagliflozin is crucial for optimizing patient care. This review explores the pharmacokinetics and pharmacodynamics of dapagliflozin and potential drug-drug interactions (DDIs). Interactions with other glucose-lowering agents and cardiovascular drugs are noted, with potential impacts on efficacy and safety. The review also addresses interactions with UGT modulators, CYP3A4 inducers, and inhibitors, emphasizing the need for careful management to avoid adverse effects and optimize therapy
Downloads
How To Cite (APA)
HASNATH P K, Dr. SREEJITH K, THABSHIRA M, FIDA P, & P P SHAHDA (August-2024). DRUG-DRUG INTERACTIONS WITH DAPAGLIFLOZIN: A REVIEW. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(8), c205-c210. https://ijnrd.org/papers/IJNRD2408223.pdf
Issue
Volume 9 Issue 8, August-2024
Pages : c205-c210
Other Publication Details
Paper Reg. ID: IJNRD_226711
Published Paper Id: IJNRD2408223
Research Area: Engineering
Author Type: Indian Author
Country: CALICUT, KERALA, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2408223.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2408223
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International UGC CARE JOURNAL PUBLICATION, Low Cost, Scholarly Open Access, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2026 - Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use.
The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the New UGC CARE Transparent Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
Transparent Peer Review Journal Publication: IJNRD operates a strict double-blind peer review system managed by 3000+ expert reviewers, ensuring ethical, unbiased, and high-quality review for every research paper.
For Indian Authors : Get a transparent peer review report from Scholar9.com for just ₹1000. View Sample Report
For Foreign Authors : A detailed peer review report is available through Scholar9.com for $20 USD. View Sample Report
Transparent Peer Review Journal Publication
⭐ Transparent Peer Review | 🕵️♂️ Double-Blind | 👨🏫 3000+ Expert Reviewers | 🇮🇳 Report for India Author ₹1000 | 🌐 Report for Foreign Author $20 | 📄 Sample Reports on Scholar9.com | 🌍 High Credibility | ⚖️ Ethical & Unbiased Evaluation
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Recently, the UGC discontinued the UGC-CARE Journal List and introduced new parameters that allow publication in Transparent Peer-Reviewed (Refereed) Journals. IJNRD is Transparent Peer Review Journal Valid As per New UGC Notification.
You can now publish your research paper in IJNRD.ORG. IJNRD is a Transparent Peer-Reviewed Open Access (Refereed Journal), UGC and UGC CARE Approved, Crossref DOI, Multidisciplinary, Impact Factor calculate by Google Scholar. As an International, open-access, and online journal, Publishing with us ensures wider reach, academic credibility, and enhanced recognition for your work.
For more details, refer to the official notice: UGC Public Notice
⭐ Low Cost ₹1570 | 📚 UGC CARE Approved | 🔍 Peer-Reviewed | 🌐 Open Access | 🔗 Crossref DOI & Global Indexing | 📊 Google Scholar Impact Factor | 🧪 Multidisciplinary
Submit Paper Online Call for Paper About IJNRD UGC CARE Approval
Important Dates for Current issue
Paper Submission Open For: March 2026
Current Issue: Volume 11 | Issue 3 | March 2026
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Mar-2026
Notification of Review Result: Transparent peer review process - your paper is evaluated by experts, and you receive acceptance or rejection updates via email and SMS.
Publication of Paper: Once all documents are submitted, your paper is published without delay, and you can instantly download your certificate and confirmation letter online.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an international open-access journal offering Low Cost Journal Publication, transparent Peer Review Journal Publication, Crossref DOI, and multidisciplinary research visibility under UGC CARE Approved Journal Publication.
Subject Category: Research Area
Approval, Licenses and Indexing: More Details
Call For Paper - Volume 11 | Issue 3 | March 2026
IJNRD.org offers low-cost journal publication starting at ₹1570 with UGC CARE Approved, refereed, peer-reviewed, open-access publishing. This multidisciplinary monthly journal, available in both online and print formats, features a strong Google Scholar-based impact factor of 8.76, Transparent Peer Review, CrossRef DOI, global indexing, fast publication, and complete metadata for maximum research visibility and citation impact across multidisciplinary domains.
Volume 11 | Issue 3 | March 2026 | IJNRD Transparent Peer Review Certificate | Submit Paper Online
⭐ UGC CARE Approved Refereed Journal | 🔍 Transparent Peer Review | 🌐 Open Access Publishing | 💰 Low-Cost ₹1570 | 🔗 CrossRef DOI & Global Indexing | 📊 Google Scholar Impact Factor 8.76 | 🧪 Multidisciplinary | Online & Print
Submit Paper Online
